Oruka Therapeutics, Inc. Quarterly Return On Assets in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Oruka Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from Q1 2012 to Q3 2024.
  • Oruka Therapeutics, Inc. Return On Assets for the quarter ending September 30, 2024 was -41.3 %, a 215% decline year-over-year.
  • Oruka Therapeutics, Inc. annual Return On Assets for 2023 was -13.3 %, a 37.1% increase from 2022.
  • Oruka Therapeutics, Inc. annual Return On Assets for 2022 was -21.2 %, a 31.5% increase from 2021.
  • Oruka Therapeutics, Inc. annual Return On Assets for 2021 was -31 %, a 3.43% increase from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -41.3 -28.2 -215% Jul 1, 2024 Sep 30, 2024
Q2 2024 -72.5 -57.7 -390% Apr 1, 2024 Jun 30, 2024
Q1 2024 -15.5 +2.45 +13.6% Jan 1, 2024 Mar 31, 2024
Q4 2023 -13.3 +7.88 +37.1% Oct 1, 2023 Dec 31, 2023
Q3 2023 -13.1 +15.9 +54.8% Jul 1, 2023 Sep 30, 2023
Q2 2023 -14.8 +16.6 +52.8% Apr 1, 2023 Jun 30, 2023
Q1 2023 -18 +14 +43.8% Jan 1, 2023 Mar 31, 2023
Q4 2022 -21.2 +9.75 +31.5% Oct 1, 2022 Dec 31, 2022
Q3 2022 -29 +1.63 +5.32% Jul 1, 2022 Sep 30, 2022
Q2 2022 -31.4 -4.28 -15.8% Apr 1, 2022 Jun 30, 2022
Q1 2022 -32 -4.63 -16.9% Jan 1, 2022 Mar 31, 2022
Q4 2021 -31 +1.1 +3.43% Oct 1, 2021 Dec 31, 2021
Q3 2021 -30.6 -1.29 -4.4% Jul 1, 2021 Sep 30, 2021
Q2 2021 -27.1 +26.2 +49.1% Apr 1, 2021 Jun 30, 2021
Q1 2021 -27.3 +29.2 +51.7% Jan 1, 2021 Mar 31, 2021
Q4 2020 -32.1 +26.5 +45.2% Oct 1, 2020 Dec 31, 2020
Q3 2020 -29.3 +34.9 +54.3% Jul 1, 2020 Sep 30, 2020
Q2 2020 -53.3 +18.9 +26.2% Apr 1, 2020 Jun 30, 2020
Q1 2020 -56.6 +24.3 +30.1% Jan 1, 2020 Mar 31, 2020
Q4 2019 -58.5 +24.7 +29.7% Oct 1, 2019 Dec 31, 2019
Q3 2019 -64.3 +33.2 +34.1% Jul 1, 2019 Sep 30, 2019
Q2 2019 -72.2 +31.3 +30.2% Apr 1, 2019 Jun 30, 2019
Q1 2019 -80.9 +32.9 +28.9% Jan 1, 2019 Mar 31, 2019
Q4 2018 -83.2 +26.9 +24.4% Oct 1, 2018 Dec 31, 2018
Q3 2018 -97.5 -4.13 -4.42% Jul 1, 2018 Sep 30, 2018
Q2 2018 -103 -21.1 -25.7% Apr 1, 2018 Jun 30, 2018
Q1 2018 -114 -49.4 -76.8% Jan 1, 2018 Mar 31, 2018
Q4 2017 -110 -56.6 -106% Oct 1, 2017 Dec 31, 2017
Q3 2017 -93.3 -48.7 -109% Jul 1, 2017 Sep 30, 2017
Q2 2017 -82.3 -46.6 -131% Apr 1, 2017 Jun 30, 2017
Q1 2017 -64.3 -34.2 -114% Jan 1, 2017 Mar 31, 2017
Q4 2016 -53.5 -20.9 -64.1% Oct 1, 2016 Dec 31, 2016
Q3 2016 -44.6 -7.35 -19.7% Jul 1, 2016 Sep 30, 2016
Q2 2016 -35.7 +9.07 +20.3% Apr 1, 2016 Jun 30, 2016
Q1 2016 -30.1 +29 +49% Jan 1, 2016 Mar 31, 2016
Q4 2015 -32.6 +17.5 +34.9% Oct 1, 2015 Dec 31, 2015
Q3 2015 -37.3 +13.9 +27.2% Jul 1, 2015 Sep 30, 2015
Q2 2015 -44.8 +2.89 +6.06% Apr 1, 2015 Jun 30, 2015
Q1 2015 -59.1 -17.7 -42.6% Jan 1, 2015 Mar 31, 2015
Q4 2014 -50.1 -4.7 -10.4% Oct 1, 2014 Dec 31, 2014
Q3 2014 -51.2 -10.3 -25.2% Jul 1, 2014 Sep 30, 2014
Q2 2014 -47.7 +3.45 +6.75% Apr 1, 2014 Jun 30, 2014
Q1 2014 -41.5 +67.5 +61.9% Jan 1, 2014 Mar 31, 2014
Q4 2013 -45.4 +66.5 +59.4% Oct 1, 2013 Dec 31, 2013
Q3 2013 -40.9 +68.2 +62.5% Jul 1, 2013 Sep 30, 2013
Q2 2013 -51.1 +59.2 +53.7% Apr 1, 2013 Jun 30, 2013
Q1 2013 -109 -40.1 -58.3% Jan 1, 2013 Mar 31, 2013
Q4 2012 -112 Oct 1, 2012 Dec 31, 2012
Q3 2012 -109 Jul 1, 2012 Sep 30, 2012
Q2 2012 -110 Apr 1, 2012 Jun 30, 2012
Q1 2012 -68.8 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.